Goldman Sachs invests in Italian medical devices

White Bridge Investment and Goldman Sachs Alternatives announced their acquisition of a controlling stake in the Italian medical equipment manufacturer Nomantick, with a value close to 700 million euros. Nomantick is a leading supplier of healthcare products and drug delivery devices, employing around 600 staff across seven factories in Europe and the United States. The company is expected to continue expanding in Europe and the U.S., the latter of which it entered last year through the acquisition of Health Line International. The deal is anticipated to be finalized in the last quarter of the year.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل